The hypothalamus initiates signaling by releasing gonadotropin-releasing hormone, which stimulates the pituitary gland to secrete luteinizing hormone and follicle-stimulating hormone. These pituitary hormones act on the gonads, directing sex-steroid production and gamete development. This linked sequence connects central endocrine signals with reproductive processes rather than treating each hormone as an independent regulator.
Luteinizing hormone and follicle-stimulating hormone both relay pituitary signals to the gonads, but the overview assigns them related, not identical, responsibilities within the reproductive system. Together, they direct gonadal production of sex steroids and support gamete development. Their coordinated activity helps connect hormonal regulation with fertility and reproductive function.
Estrogen, progesterone, and testosterone are sex steroids produced through gonadal activity and are relevant to reproductive function. Their clinical importance extends across sexual development, fertility, menstrual and sexual disorders, puberty, and menopause. Evaluating these hormones can therefore help place reproductive symptoms or developmental changes within the broader function of the endocrine reproductive system.
Human chorionic gonadotropin is associated with the placenta and provides a hormonal link to pregnancy. Its inclusion in clinical hormone evaluation helps distinguish pregnancy-related endocrine activity from other reproductive states. This makes it relevant when reproductive medicine addresses pregnancy, fertility assessment, or the interpretation of hormone measurements in relation to placental function.
Clinicians use reproductive hormone measurements to support evaluation of infertility, menstrual and sexual disorders, puberty, pregnancy, and menopause. The results are interpreted in relation to the hormone-producing organs and the hypothalamic-pituitary-gonadal axis. This approach can help assess whether reproductive changes involve gonadal function, pituitary signaling, pregnancy-related activity, or another endocrine-related condition.
Hormone measurements and targeted therapies both contribute to reproductive care. Measurements can inform assessment before or during fertility-related evaluation, while targeted therapies support contraception and assisted reproduction. These applications demonstrate how knowledge of the axis, gonadal hormones, and pregnancy-associated signals can be translated into approaches for managing fertility and reproductive planning.